By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A team of researchers from Massachusetts General Hospital, Harvard Medical School, and Yale University has demonstrated the feasibility of routinely genotyping lung cancer samples for alterations in more than a dozen suspicious genes in a clinical setting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.